NEVVI Medicare utilization intelligence

← back

MEHTA, JAYESHMD NPI 1790718617 Clinician

Hematology · CHICAGO, IL

Specialty Hematology — from billed Medicare claims
In practice about 39 years since medical school (class of 1987, self-reported to CMS)
Location CHICAGO, IL · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 45 codes billed · 67,664 disclosed services (CY2024 — most recent year in data)
Current groups
member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026
RCI (WRS) LLC
2026
NORTHWESTERN MEDICAL FACULTY FOUNDATION
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2009-07

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9380 Injection, teclistamab-cqyv, 0.5 mg
J9263 Injection, oxaliplatin, 0.5 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
J1453 Injection, fosaprepitant, 1 mg
J9041 Injection, bortezomib, 0.1 mg
J0897 Injection, denosumab, 1 mg
J0461 Injection, atropine sulfate, 0.01 mg
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
J9190 Injection, fluorouracil, 500 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J9206 Injection, irinotecan, 20 mg
99443 Telephone medical discussion with physician, 21-30 minutes
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96375 Injection of additional new drug or substance into vein
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96413 Administration of chemotherapy into vein, 1 hour or less
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96372 Injection of drug or substance under skin or into muscle
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
36415 Insertion of needle into vein for collection of blood sample
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J2997 Injection, alteplase recombinant, 1 mg
96415 Administration of chemotherapy into vein, each additional hour
99239 Hospital discharge day management, more than 30 minutes
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
96417 Administration of additional new drug or substance into vein, 1 hour or less
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
36593 Declotting of central venous tube
G0008 Administration of influenza virus vaccine
96409 Administration of chemotherapy into vein using push technique
96411 Administration of additional new drug or substance into vein using push technique
J1200 Injection, diphenhydramine hcl, up to 50 mg
J3490 Unclassified drugs
90662 Influenza vaccine split virus, preservative free
38241 Transplantation of patient-derived stem cells

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.